Reviva Labs, a popular brand of cosmetics, must either prove its products plump skin, regenerate collagen and lighten age spots, or stop claiming they do, the Food and Drug Administration said Wednesday.
The FDA issued a warning to the New Jersey-based company over medical claims it makes for a batch of its products sold online and in stores. The government watchdog says if the products can do what the company claims on its website, it has to register as a new drug and go through the formal approval process.
It's the latest in a series of actions the FDA, which cannot regulate cosmetics when they're sold just as cosmetics, has started taking against cosmetics companies in recent years.
U.S. & World
"We are in the process of changing our copy and eliminating all claims to which the FDA refers," Reviva President Stephen Strassler said in a statement.